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ABSTRACT 
Autophagy was first isolated as a marker of starvation but has since then been identified 
and implicated in a variety of process both pathological or not. Lysosome density within a cell 
has long been used as a marker of activity of this pathway, as it represents the final location of 
degradation. Under normal conditions, lab strains of Drosophila melanogaster exhibit a low 
lysosome density considered to be universally observed. When challenged with starvation, this 
activity is expected to increase 2fold. We do not know if these characteristics are representative 
of natural populations, or the regulatory factors used to control the lysosome density within 
tissues.  
By phenotyping 178 lines of the Drosophila Genetic Reference Panel for their lysosome 
density under resting and starved states, we were able to identify a previously uncharacterized 
variance in lysosome density phenotypes. Resting variation included multiple lines displaying an 
unusually dense lysosome phenotype previously not observed in lab strains. Furthermore, a 
Genome Wide Association Study performed on this data revealed that the gene sets associated 
with variance in resting and starved lysosome density were non-overlapping. Finally, RNA 
interference studies identified 4 previously non-implicated regulators of lysosome density; 
Myosin61F and corazonin as negative regulators and kin17 and elk as positive regulators.  
This analysis presents a more complete picture of natural variance of lysosome density, 
and thus autophagy activation, as well as identifies novel regulators that may be responsible for 
controlling this observed variation.  
 
 
  
 
CHAPTER 1.    GENERAL INTRODUCTION 
Cells are delicate living machines, requiring a slew of different pathways to function 
properly. One of those pathways can be generally referred to as the autophagy pathway, although 
it comprises multiple types of actions. From the Greek "auto"-self and "phagy" –eating, 
autophagy allows cells to recycle damaged organelles and unused or malfunctioning proteins into 
their component parts, thus providing energy back to the cell (Codogno et al. 2011). This 
pathway is stimulated in cells as a housekeeping mechanism throughout their lives and can also 
be up-regulated in situations of stress to boost internal access to nutrients.  
The inception of autophagy characterization was in rat liver tissue when Dr. Christian De 
Duve identified vesicles termed "dense bodies", containing a very high concentration of various 
proteases and hydrolases (De Duve et al. 1955). This structure later termed "lysosome" is one of 
the central players in the autophagic process. This organelle is responsible for the breakdown of 
all material brought to it and is critical for proper function of the cell. The next landmark 
discovery happening in mouse kidney cells, where a secondary vacuole was identified as 
containing protein aggregates as well as various organelles including mitochondria (Arstila & 
Trump 1968). The presence of this specialized double membrane-bound vacuole, later termed 
"autophagosome", could be induced in the cell using stress assays, at which point it was 
established that nutrient stress was a very strong predictor for the presence of this structure. It 
was observed that while glucagon could induce its presence, insulin would repress its formation 
in the cell, thus cementing the function of these structures as being tightly linked with the 
nutritional state in the cell (Deter et al. 1967). The autophagosome would then be shown to fuse 
with the lysosome, losing one of its membrane layers in the process and allowing its cytosolic 
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contents to be degraded by the enzyme-rich media of the lysosome. This stage is coined 
"autolysosome". Once all content has been degraded they will then be excreted back into the 
cytoplasm (Arstila & Trump 1968).  
This general pathway is regulated by a wide array of dynamic protein interactions each 
tightly regulated by sets of autophagy genes. Early nomenclature was diverse, with some genes 
identified by the associated phenotype, or model organisms in which the discovery was made. 
This was later unified under the ATG (autophagy gene) umbrella, which is now used to refer to 
most of the genes involved in this pathway (Klionsky et al. 2003). The first of those genes was 
isolated in yeast, in a landmark study by Dr. Yoshinori Ohsumi, which identified 15 mutants in 
yeast that failed to survive long periods of starvation (Tsukada & Ohsumi 1993). This study also 
established the crucial role of autophagy specifically under nutritional challenge, as these 
mutants did not exhibit growth defects under nutrient-rich conditions (Suzuki et al. 2011). In the 
years since the ranks of characterized ATG genes have grown to more than 30 genes, and this 
pathway has been characterized in numerous other model organisms. Subsequent studies 
characterized both function and interaction of key proteins required for the proper function of the 
pathway (Ohsumi 2014). 
 
mTOR: The Upstream Integrator 
 
One of the major signaling controller pathway associated with autophagy is the mTOR 
pathway, a multifunctional signaling node downstream of the insulin pathway (Noda & Ohsumi 
1998). The mechanistic target of rapamyacin, or mTOR for short, forms two distinct complexes 
within the cell, each with separate functions (Helliwell et al. 1994). Here we will focus on 
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mTOR Complex 1 (mTORC1) which directly interacts with autophagy. This complex is 
composed of mTOR itself and three associated proteins (Raptor, GbetaL and Deptor) and 
integrates signal from amino acid concentration, energy levels, stress cues and growth factor 
levels to ultimately promote cellular growth (Beck & Hall 1999; Kim et al. 2002; Tokunaga et al. 
2004). It is highly activated by the Rheb protein, a small GTPase, which can be found embedded 
in the lysosome membrane (Kundu 2011). When active, mTORC1 will repress autophagy by 
phosphorylating Atg13, a subunit of the Atg kinase complex, thus stopping the activation 
cascade (Chang & Neufeld 2009).  
When nutrient stress is felt, mTOR is unable to phosphorylate Atg13 which triggers the 
autophagy activation cascade (Chang & Neufeld 2009). The specific mechanism of regulation is 
still unknown, but localization of mTORC1 provides a potential mechanism. mTORC1 has been 
shown to localize to the lysosome membrane when amino acid concentration is high, which 
allows it to complex with its co-activator Rheb (Zoncu et al. 2011). This highly activates 
mTORC1, thus repressing autophagy when nutrients are plentiful. Another mechanism of 
autophagy activation is also hypothesized to be due to colocalization of mTOR with LC3/Atg8 
on the autophagosome membrane, although its specific function at this stage is unknown 
(Kabeya et al. 2000). 
 
Molecular Mechanisms of Autophagy 
 
Like all cellular processes, autophagy relies on complex protein interaction to carry out 
its functional goal within the cell. Proper regulation of each component is crucial to ensure that 
the pathway activates correctly and does not yield adverse effects within the cell. In addition, 
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different types of autophagy (macro, micro or chaperone-mediated) have different mechanisms 
for delivering cargo to the lysosome.  
 
Figure 1.1: Schematic representation of the autophagy process within the cell. Cargo is engulfed 
and sequestered in the autophagosome, then transported to the lysosome. Fusion of the two 
vacuoles allows the cargo to be broken down by the enzyme-rich media of the lysosome. 
Products are then excreted back into the cytoplasm. 
Macro-autophagy is a complex system requiring the formation of an autophagosome to 
engulf and transport cargo to the lysosome for degradation. Each step in the process is tightly 
regulated by over 30 associated genes. This type of autophagy may be specific to targets marked 
for degradation, or nonspecifically activated as a response to nutrient stress.  
 Of particular interest, this process also includes the recycling of damaged 
mitochondria (mitophagy) which is very important to safeguard the cell from damage (Otto et al. 
2003).  
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While this process can occur non-specifically if the cell is experiencing extreme nutrient 
stress, it is primarily targeted to limit cytotoxic conditions, clear damaged organelles, and 
proteins and recycle them into usable components. 
Micro-autophagy is used to refer to a process lacking any secondary chaperone structure, 
where the lysosome itself will engulf cytosolic elements for direct degradation (Sahu et al. 2011).  
Chaperone-mediated autophagy does not require an autophagosome, but it does require 
specific chaperone proteins. These will recognize a motif similar to the KFCRQ pentapeptide 
and recruit those proteins for degradation in the lysosome using LAMP receptors as membrane 
interfaces (Bejarano & Cuervo 2010). Here, we will focus on macro-autophagy, hereafter 
referred to as simply autophagy.   
Autophagy is mediated by a host of ATG genes and other related proteins, the first of 
which, ATG1 (a serine/threonine kinase) was identified in 1993 (Tsukada & Ohsumi 1993). 
Since that first identification, dozens of other critical Atg genes have been identified.  
Autophagy is located downstream of the mTOR pathway, a key integrator of nutrient 
sensing signals in the organism. In a nutrient rich environment, mTOR will induce 
hyperphosphorylation of Atg13, thus preventing it from complexing with Atg1 (Chang & 
Neufeld 2009). A secondary feedback loop reinforcing the activity of S6K (a downstream 
effector of mTOR) also works to inhibit the formation of the Atg1/Atg13 complex (Lee et al. 
2007). In its inactive, hyperphosphorylated form, Atg1 will allow S6K to be phosphorylated, 
thus activating it and promoting cell growth. This, in turn, will promote mTOR activation, and 
keep both Atg1 and Atg13 inactive (Scott et al. 2004).  
 In a nutrient-depleted environment, Atg13 will very quickly dephosphorylate and 
complex with Atg1 and Atg17, thus forming the Atg1/Atg13 initiation complex. As a result, S6K 
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will be inhibited, halting cell growth. While this interaction is well understood, it's hypothesized 
that S6K has other regulatory functions in the autophagy pathway, but these interactions are 
currently not well understood (Lee et al. 2007). 
Once the initiation stage has been reached, and the Atg1/Atg13 complex is active within 
the cell, beclin1 and LC3 proteins are recruited to the phagophore membrane, and start 
embedding themselves (Xie et al. 2008). LC3, also referred to as Atg8, is a ubiquitin-like protein 
that will undergo further post-translational modifications as the autophagosome membrane 
expands (Pankiv et al. 2007). Multiple Atg genes act in succession to modify LC3/Atg8 and 
activate it, this step is commonly considered to be the most complex and potentially error-prone, 
as gene expression of all participating proteins needs to be tightly regulated. Atg4, a cysteine 
protease, is the first to interact, cleaving the C-terminal location and exposing a glycine. This 
activation stage is referred to as LC3-I and needs to undergo further modifications to reach the 
final active stage called LC3-II (Tanida et al. 2004). Concurrently, Atg 12 and Atg5 will also 
form a secondary complex, with the help of Atg10 and Atg7. The Atg12/Atg5 complex will 
require one more interaction (Atg16) before the mature complex is integrated into the growing 
phagophore membrane (Mizushima et al. 1999).  This complex, although not essential, will then 
facilitate the final modifications of LC3-I by adding PE (phosphatidylethanolamine), at which 
point Atg8 is generally referred to as LC3-II.  
The addition of PE allows LC3/Atg8 to be inserted into the autophagosome membrane as 
it grows, encapsulating cargo (Papinski & Kraft 2014). The conjugation status of Atg8 is 
recognized as a strong marker of autophagy, with free cytosolic Atg8 being a marker of nutrient-
rich conditions, and the presence of lipidated Atg8 being strongly associated with an active 
autophagy pathway.  
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Once the autophagosome is fully formed, its fusion to the lysosome is mediated by 
multiple agents, including LAMP-1 a lysosomal transmembrane protein (Saftig et al. 2008). At 
this step, we now refer to the fused structure as an autolysosome, and degradation of both cargo 
and original autophagosome membrane will begin. Of particular note is the cathepsin class of 
proteases, which possess a cysteine in their active group and thus may be susceptible to oxidative 
modifications and redox regulation (Cullen et al. 2009).   
 The resulting pool of free amino acids is then released into the cytosol to be 
reused by the cell in metabolic processes (Yang et al. 2006). 
 
Autophagy, Disease and Aging 
 
At its core, autophagy is a recycling process, but this basic mechanism has implications 
in multiple cellular fate outcomes. By lessening the effect of malfunctioning components of the 
cell, it promotes optimal function and prolongs the functionally healthy life of the cell. It can 
also, through intense and nonselective degradation of cytosolic content, trigger apoptotic 
conditions in the cell (Marino et al. 2014). Well regulated, autophagy allows the cell flexibility 
when challenged by environmental triggers and allows it to survive conditions that would 
otherwise destroy the organism. On the other hand, the pathway can also damage the cell, by 
nonspecifically destroying essential viable components. This wide array of consequences arising 
from a singular process contributes to the interest in autophagy associated with various disease 
states. Here we will review its specific know interactions within the domain of aging, and 
implications for other diseases that arise with age.  
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Because of its action as a regulator of damaging components within the cell, autophagy 
has been theorized to have an effect on the process of aging, namely that an optimally functional 
autophagy machinery could prolong lifespan (Vellai 2009; Markaki & Tavernarakis 2011; 
Madeo et al. 2010). Aging is a complex multi-partite phenomenon, but many of its markers can 
be considered to be affected by autophagy. Literature shows that in multiple tissues, aging is 
linked with a down-regulation of key autophagic genes although the process by which these 
genes are down-regulated is still unknown (Bejarano et al. 2014). This would lead to lessened 
clearance ability and overall increased stress burden on the cell.  
In particular, it has been shown that aging cells are more likely to misfold proteins, and 
thus accumulate nonfunctional protein aggregates at a faster rate (Ravikumar et al. 2010). This, 
coupled with a downregulation of autophagy can contribute to some of the aging phenotypes 
observed, mainly increased cytotoxicity. Since the source of the down-regulation is still 
unknown, studying the triggers of autophagy and its regulatory pathway is critical to try and 
safeguard a strong activation as the organism ages. In addition, as multiple pathways are 
integrated to activate autophagy, it is also very important to consider their dysregulations as time 
passes, and how this might affect activation of autophagy.  
In addition, as tissues age, mitochondria become less effective and result in a higher 
occurrence of reactive oxygen species (ROS) being produced as the mitochondrial machinery 
becomes deregulated. A small amount of ROS is known to be crucial to the proper functioning of 
a cell, and its complete elimination would result in cell death, but large quantities are highly 
damaging to the cell and need to be cleared away (Sena & Chandel 2012). In this case, the action 
of autophagy as a clearance mechanism for dysregulated mitochondria could prevent the 
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accumulation of ROS to damaging levels, thus once again safeguarding the cell's integrity (Twig 
et al. 2008).  
Considering the current consensus in the literature regarding the cytoprotective nature of 
autophagy, and its association with common aging phenotypes, there is a drive to leverage the 
autophagy machinery to lengthen both health and lifespan. Specific Atg genes have been shown 
to function as lifespan extenders, including a milestone study in C. elegans (Hansen et al. 2008). 
Other studies have shown that tissue-specific overexpression of Atg7 in the liver can improve the 
tissue's function when challenged by obesity conditions (Zhang & Cuervo 2008). Finally, a 
general overexpression of Atg5 in mice was shown to increase lifespan by 17% (Pyo et al. 2013). 
While these studies are encouraging, they do not yet cross into the domain of human 
therapeutics. All of these discoveries are limited to non-human model organisms, which does not 
guarantee that processes would carry over to different organisms. It is also critical to better 
understand the regulators of autophagy if we wish to apply that knowledge to human medicine. 
Most currently, therapies targeting known upstream activators of autophagy such as rapamyacin 
treatments targeting and down-regulating mTOR are promising leads into better managing 
autophagy as a factor of aging, and diminishing tissue damage (Harrison et al. 2009; Bjedov et 
al. 2010). 
There have been some other leading studies in the field of longevity showing that one of 
the clinical ways to increase longevity is calorie restriction. In laboratory models, mice fed a 
restricted diet (1/3 fewer calories than a standard diet) saw an extension of their lifespan, an 
increase in lean body mass, and an overall healthier lifespan as compared to mice fed a standard 
caloric diet (Wohlgemuth et al. 2007).  
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An overall decrease in calorie causes insulin signaling to drop, thus impacting mTOR 
dependent pathways including autophagy (Blagosklonny 2010). It is hypothesized that the 
calorie restriction activates autophagy, leading to a cell that more actively cleanses itself and 
recycles internal components. This more active pathway leads to reduced cytotoxicity as the 
animal ages and retards loss of tissue homeostasis at the organismal level.  
While this clinical information is of great interest in the field of longevity, it becomes 
hard to apply in human settings due to the restrictions of the diet. In addition, while this 
demonstrates a strong link between insulin metabolism and aging, the specific interactions that 
lead to this longevity are poorly understood.  
Key factors that integrate cellular information and regulate these various pathways, 
including autophagy, are affected in ways we do not yet fully understand. However, studies like 
these that show a strong correlation between mTOR activity, autophagy and longevity are the 
basis for searching and understanding the missing factors that regular cellular mechanisms. By 
elucidating which factors are currently missing, we could bring this type of therapy to the greater 
human population and leverage its benefits for the human race.  
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CHAPTER 2.    THE POWER OF GWAS: LEVERAGING GENOME WIDE 
ASSOCIATION STUDIES TO IDENTIFY NOVEL REGULATORS OF AUTOPHAGY 
IN DROSOPHILA MELANOGASTER 
Axelle Weeger and Hua Bai 
Iowa State University, aweeger@iastate.edu. Corresponding author.  
Iowa State University, hbai@iastate.edu 
Modified for a manuscript to be submitted to BMC Genomics 
Abstract 
Background 
Autophagy has long been studied, and its activation during nutrient stress is well 
characterized. What is less studied, are whether the conclusions on pathway behavior in 
laboratory strains translate to wild populations. We propose that phenotyping a panel created 
from wild-caught Drosophila melanogaster will yield valuable data on the variability of 
autophagy both pre and post nutrient stress. Furthermore, we propose that applying a Genome 
Wide Association Study pipeline to this phenotypic data will allow us to identify and validate 
candidate SNPs associated with high variance in this population, and thus identify novel 
regulators of autophagy.  
Results 
Using 178 lines of the DGRP, we were able to demonstrate that wild type D. 
melanogaster populations exhibit more variability in autophagy that previously characterized. In 
addition, the sets of genes most associated with variability in pre and post stress datasets did not 
overlap significantly. Finally, RNAi validation identified 4 novel regulators, kin17 and elk being 
negative regulators while Myosin61F and corazonin are positive regulators.  
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Conclusions 
 The autophagy behavior in wild type laboratory strains of D. melanogaster does not 
adequately model the phenotypic variance found in natural populations. This study also indicated 
that regulators involved in basal autophagy regulation may be different from those that are 
responsible for post-stress activation. Finally, the full regulatory network of autophagy is still not 
fully delineated, as new regulators are still being identified and characterized. We present here an 
effective method to investigate complex phenotypes in natural populations and identify minor 
regulators responsible for this variation.  
 
Introduction 
 
In times of starvation, the body will do everything it can to maintain homeostasis. When 
nutrients cannot be brought to the cell from outside, it will instead look inwards to its own 
components as a resource. Autophagy, literally “self-eating”, will be triggered to start non-
specifically engulfing cytoplasmic components and degrading them. This process allows the cell 
to maintain essential function by recycling itself [1]. Autophagy as a mechanism has already 
been widely studied, and the essential pathways and regulators have been characterized [2]. 
What has been less studied, are the subtler regulators of the process. We understand autophagy to 
be active at a low level in well fed organism, acting as a housekeeping system to help maintain 
homeostasis. This basal level is greatly increased when nutrient stress is felt, but we do not know 
as of yet if these basal and stress levels are representative of natural variation [3].  
To investigate such potential variance, and its regulators, we used an established wild 
type panel, the Drosophila Genetic Reference Panel (or DGRP) and its associated Genome Wide 
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Association Study (GWAS) pipeline [4]. Composed of over 200 Drosophila melanogaster 
isogenic lines, the panel was established using wild caught specimens. As such, it provides us 
with an unparalleled resource to study naturally occurring genetic variation. By its very nature, 
the panel is not concerned with extreme, lethal variation, but instead can be used to explore the 
inherent pleiotropic nature of complex phenotypes, such as characterizing the variance of 
autophagy before and after nutrient stress. 
We will be using 178 lines of the DGRP to investigating an end-stage phenotype 
associated with autophagy, the lysosome density within the cell [5]. This indirect assay has been 
used extensively to characterize autophagy phenotypes, as such we consider it to be a valuable 
reporter. The GWAS protocol will allow us to identify highly correlated SNP candidates, which 
will then undergo RNA interference validation of function.  
This particular combination of tools allows us a previously unavailable view of 
autophagy in natural populations, as well as an opportunity to identify previously 
uncharacterized regulators that influence the regulation of autophagy.  
 
Methods 
 
Fly Husbandry and Tissue Dissection 
Overview 
Flies from the Drosophila Genetic Reference Panel (DGRP), created by the MacKay lab 
as a platform to run Genome Wide Association studies (GWAS), were used to record phenotypic 
variation associated with autophagy (Mackay et al. 2012).  
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Progenitor flies were collected by the MacKay lab at the Raleigh, NC Farmer's market. 
Progenitor gravid females were inbred via full sibling mating for 20 generations, to produce the 
viable lines currently included in the panel. Current lines included in the panel are isogenic and 
fully inbred.  
All obtained lines were subsequently sequenced using Illumina technology, and unique 
Single Nucleotide Polymorphisms (SNPs) were mapped back to each line. Globally, this 
sequencing effort yielded over 4 million unique SNPs within the panel, which can be queried 
using a Genome Wide Association tool developed specifically for this panel.  
The DGRP panel was obtained from Bloomington Stock Center, where the full panel is 
maintained. 
Fly Husbandry 
After quarantine and screening for mites, 20 females and 5 males of selected DGRP lines 
were seeded into vials containing 6ml of 3% yeast food. The standard recipe for fly food (1 
batch) contains 850ml of water, 7.9g of Agar (USB, Cat#10654), 25g of yeast (Genesee 
Scientific, Cat#62-108), 52g of yellow cornmeal (Fisher Scientific, Cat#NC9349175) and 110g 
of granulated sugar (C&H commercial). Tegosept (Methyl 4-hydroxybenzoate, Genesee 
Scientific Cat#20-258) is also added to prevent molding (2.38g, dissolved in 9.2ml of ethanol).  
Flies were allowed to mate and lay eggs for 48h before transfer. Three biological 
replicates were created.  
Flies were the kept in a 25°C incubator, with 60% moisture during development.  
As biological replicates reached eclosion, emerging adults were collected by date of eclosion, to 
allow uniform aging across genotypes.  
 15 
Flies were aged for five (5) days, with both sexes present to reduce instances of death by 
drowning in the exuded moisture.  
At day five (5) of age, males and females were separated, and treatment was set up.  
Males were chosen for the experiment, as their starvation time is faster than females. 
Treatment and Dissection 
Ten (10) flies were in the control group and given normal food for 16 hours.  
Ten (10) flies were in the treatment group were starved for 16 hours.  
 Starvation: 1.5mL of 1X PBS was placed on an absorbent wipe folded and placed at the 
bottom of a vial. This prevented desiccation and provided minimum electrolytes while restricting 
all caloric intake. 
After the 16-hour treatment, flies were collected for dissection.  
Flies were knocked out using Flynap (Carolina Biological Supply, # 173010). 
Six (6) flies for each treatment were placed in Vaseline dorsal side down and dissected. 
The thorax and head were removed, along with the last segments of the abdomen (Fig. 
2.1, cuts 1 and 2). The carcass is then transferred to a drop (50 uL) of 1X PBS to prevent 
desiccation. Entrails were then gently pulled out of the carcass, allowing more freedom of 
movement to create two lateral cuts (Fig. 2.1, cuts 3 and 4) and remove the ventral panel. This 
exposes the relevant tissue, the fat body.  
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Figure 2.1: Dissection of the dorsal fat body in D. melanogaster. Cuts 1 and 2 separate the 
abdomen and remove internal connections of the gut and other internal organs to the cuticle. Cuts 
3 and 4 are lateral and allow the removal of the ventral cuticle. This allows a clear visualization 
of the dorsal fat body. 
The fat body was selected as a testing organ because of its physiological similarity to 
human adipose tissue. This tissue is responsible for energy storage in the fly, in the form of fat 
droplets, which can then be degraded when nutrient stress is detected. This tissue is very reactive 
to nutrient stress, and as such is a very good model organ to study the variability of autophagy 
activation in different genetic backgrounds. 
Carcasses were then incubated with 100nM LysoTracker Red DND-99 (Invitrogen, 
#L7528) at room temperature for 3 minutes.  
LysoTracker was selected as a dye because of its affinity for acidic organelles within the 
cell. It has been shown to target lysosome reliably and efficiently, allowing for a consistent 
staining across all dissections. Some staining of the endosome is also possible, but LysoTracker 
is considered to be most accurate at staining lysosome and autolysosome within cells [6].  
During incubation, a glass bridge was created on the slide, to prevent carcasses from 
getting crushed by capillary action. 
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Imaging 
Carcasses were mounted to a slide using 1X PBS and capillary action to maintain 
position.  
The fat body stain was then imaged using an Olympus BX51W1 fluorescent 
microscope fitted with a TRITC filter and imaging data was collected using the associated 
Olympus cellSens software. 
An overview of the whole carcass was taken at 10x magnification, and a 19-slice 
(.75um offset) z-stack was taken at 20x magnification for each carcass. 5 replicates were 
imaged for each treatment. 
 
Image Processing and Quantification 
After acquisition, images were processed using a constrained iterative deconvolution 
process. Image data was quantified using the following protocol: 
Three (3) circular areas were isolated on the z-stack, each measuring 100nm in 
diameter. The location of the areas of sample was as random as the sample allowed, with an 
aim for optimal coverage of representative areas of the sample and minimizing potentially 
confounding areas (locations of abnormally high tissue staining, pericardial cells, cardiac 
muscle, etc).  
The cellSens software was then utilized to count the total number of the objects 
present within these three measuring areas. This measure includes all 19-vertical stack for 
each sample, across the three regions of interest.  
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Genome Wide Association Study 
Overview 
Genome Wide Association Studies (GWAS) have established themselves as solid and 
competent models to pull putative information from large sequencing experiments. Through 
statistical these studies allow the selection of candidate SNPs most correlated to a specific 
phenotype of study. This is particularly powerful, as many phenotypes are incredibly 
complex and multigenic, and thus cannot be isolated through single mutant screens. In the 
context of D. melanogaster, much of the genome remains non-annotated, with a large portion 
of proteins whose function remains cryptic.  
GWAS mobilizes the increasing power of sequencing as well as relatively simple 
statistical methods to produce vast amounts of data. These studies rely on Single Nucleotide 
Polymorphism (SNP) to better understand the influence certain genes have on overall 
phenotypes. Each genomic location can either be a major SNP, which occurs in more than 
50% of a population, or a minor SNP. Generally speaking, when referring to a SNP, the 
literature is referring to the minor SNP.  Once a phenotype has been identified and quantified 
within a population, mass sequencing will reveal which SNP is present throughout the entire 
genome. This information itself can be valuable, but it is not the end goal of a GWAS.  
After the genomic information is obtained, a massive Analysis of Variance (ANOVA) 
test is performed. Some other methods are also used depending on the study's hypothesis, 
including contingency tables and logistic regression. A general model of interaction needs to 
be selected, in regard to the epistatic relationship between major and minor SNP. This model 
also needs to consider whether allelic effects are multiplicative or additive, a factor that can 
affect how correlated a genotype is to phenotype. Factors that are known to influence the 
phenotype also need to be taken into account when designing the model, such as age, weight, 
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sex and many others. Taking all of these parameters into consideration, the GWAS then runs 
a corrected ANOVA test on every single base pair of the sequenced genomes and tests it 
against contribution to the phenotype of choice. A significance level of 0.5 is the most 
commonly used threshold of significance, but due to the extremely large number of test, a 
statistical correction is usually employed to minimize false positive hits. 5% of 500,000 tests 
is still a very high level of false positive results. To that effect, a Bonferroni correction is 
most commonly used, which decreases the alpha value by dividing it by the number of tests 
performed. This usually decreases the number of false positives down to acceptable values. 
The MacKay lab established a specific pipeline using Partial Lease Regression (PLS) models 
to most accurately call relevant SNPs, which can be found in the supplementals of their 
landmark paper on the establishment of the DGRP [7]. 
After the analysis is complete, a list of SNPs most likely to be associated with the 
phenotype is produced, with smaller p-values indicating a higher likelihood of an effect. It is 
important to note that all the GWAS provides are correlations, and that further testing is 
absolutely necessary to validate whether a particular gene is involved in the control of a 
particular phenotype. 
Analysis 
Once the autophagy phenotyping data was collected for each genotype two data sets 
were created.  
One set, termed the "Fed" dataset, contained the raw untransformed LysoTracker 
count for all control treatments of each genotype. This represents the level of 
autophagy/lysosome activity in a well-fed, healthy fly.  
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The second set, termed "Foldchange" contained data representing the foldchange in 
LysoTracker count from the fed and the starved treatment for each genotype. This represents 
a measure of autophagy activation, following stress (starvation). 
Each data set was independently submitted to the GWAS software developed by the 
McKay lab which can be found at the following web address: http://dgrp2.gnets.ncsu.edu/. 
Data sets were then visualized using Manhattan plots generated using the code in Appendix 
A.  
Candidate Selection 
Upon recovering GWAS results, individual SNPs were screened for potential 
candidate genes that are involved in autophagy regulation.  
The screen was conducted in two parts, one purely mathematical in nature, the next 
with a subjective value assigned to each SNP. 
SNPs were chosen if either of the following criteria was met: 
-Single mixed p-value was 10E-7 or lower.  
-SNP was located in a location that disrupted proper protein function (Non-
synonymous, start/stop codon) 
-Literature evidence indicated the SNP-associated genes might be relevant to 
autophagy control, regardless of the two previous criteria.  
 
Functional Validation Using RNAi 
Overview 
Following candidate selection, transgenic RNAi lines were ordered for the multiple 
candidate genes to verify their roles in autophagy control. These lines were crossed to a gene-
switch fat-body driver (S106-GS) to induce knockdown of the gene of interest only in adult 
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fat body. The S106-GS line is a modified Gal4 driver that enables targeted temporal 
activation of RNA interference models using drug inducers [8]. The GAL4 gene is fused with 
the activation domain for p65 and a ligand-binding domain for the human progesterone 
receptor. In the presence of the inductor, antiprogestin drug RU486, also known as 
Mifepristone (Cayman Chemical, CAS #84371-65-3), the fusion protein is able to bind to the 
UAS domain and induce transcription. RU486 is also used in the medical field as an 
abortifacient drug. 
In this way, the Gal4 driver associated with the fat body tissue is not constitutively 
active throughout the development of the organism and is instead dormant until activated at 
the desired time point. This is done to limit mortality in early development, as well as general 
organismal stress that would influence the autophagy process in the organism. Using this 
system, we can be better assured that the phenotype observed is a direct consequence of the 
removal of the target protein from the individual and not a consequence of developmental 
issues due to the lack of the target protein. 
Fly Husbandry 
Flies were reared in standard conditions previously detailed.  
 Mating pairs of ten (10) virgin females of S106-GS-gal4 line and five (5) UAS-RNAi 
males were established.  
 Mating pairs were allowed to lay eggs for 24 hours, before being transferred to a new 
vial to produce a replicate.  
 After eclosion, males were separated from females before treatment. Lines that 
contained a balancer gene were carefully screened for the absence of the balancer trait in the 
experimental progeny.  
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 Treatment- Seven to ten (7-10) males were fed on food containing 200 µM RU486 
for 6 days, with fresh food being offered every 2 days.  
 Control- Seven to ten (7-10) males were fed on food containing 0 µM RU486 for 6 
days, with fresh food being offered every 2 days.  
 At day six (6) of age, males were dissected and imaged using previously established 
protocol.  
 
Functional Validation of Knockdown via qRT-PCR 
Overview 
To ensure that all previous RNAi testing could be trusted, we additionally performed 
a qRT-PCR assay to verify that the UAS-RNAi lines we were using were indeed capable of 
inducing knockdown of the gene of interest in. A whole body driver (Da-GS-gal4) was used 
in this instance, to maximize potential expression and confirm the viability of the RNAi lines 
being used. 
Fly Husbandry 
Flies were reared in standard conditions previously detailed.  
Mating pairs of ten (10) virgin females of Da-GS-gal4 line and five (5) UAS-RNAi 
males were established.  
Mating pairs were allowed to lay eggs for 24 hours, before being transferred to a new 
vial to produce a biological replicate.  
After eclosion, males were separated from females before treatment. Lines that 
contained a balancer gene were carefully screened for the absence of the balancer trait in the 
experimental progeny.  
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Treatment- Four (4) males were fed on food containing 200 µM RU486 for 4 days, 
with fresh food being offered every 2 days.  
Control- Four (4) males were fed on food containing 0 µM RU486 for 4 days, with 
fresh food being offered every 2 days. 
RNA Extraction 
Protocol adapted from Life Technology Cat #15596026 
RNA was extracted from the treatment and control males, using the full body. 4 males 
were added to a sample tube containing 500ul of Trizol reagent (Life Technology 
#15596026) and a 5mm stainless steel bead (Qiagen #69989). The samples were then 
homogenized using a Tissuelyzer II (Qiagen, Manufactured by Retsch), for 2 minutes at a 
frequency of 30/s. Samples were incubated at room temperature (RT) for 10 minutes (min), 
before adding 100 µl of chloroform per sample and resting an additional minute. Samples 
were then vortexed, (10 seconds, twice) and further incubated for 8 min at RT. They were 
then centrifuged at 12000 g, at 4°C, for 15 minutes.  
The supernatant (~250 µl) was removed to a fresh RNase free tube, and we added 250 
µl of isopropanol.  After a gentle shaking, samples were incubated at RT for 15 min and 
centrifuged at 12,000g, at 4°C, for another 15min. 
All samples were decanted and washed with 700 µl 75% RNase free then centrifuged 
at 7,500g at 4°C for 5 minutes. This step was repeated twice then the pellet was allowed to 
air dry for 15 minutes. We re-suspended each sample in 17µl Nuclease-free H2O.  
Samples were then treated using Turbo DNA-free DNase treatment (Ambion, cat # 
AM1907). Each sample received 0.1 volume 10X TURBO DNase Buffer and 1 uL TURBO 
DNase before incubation at 37°C for 30 minutes. 
 24 
Samples were then centrifuged at 10,000g at 4°C for 2 minutes to pellet DNase 
inactivation reagent, and the supernatant was transferred to a fresh tube. RNA concentration 
was assessed using Nanodrop system. 
cDNA Synthesis 
The reaction was set up as follows:  
4 ul 5x qScript reaction mix, 1 ul qScript reverse transcriptase (QuantaBio, #101414), 15 ul 
RNA + dH2O (total volume 20ul). RNA volume was adjusted to contain 2ug of RNA.   
 Reaction was run in PCR machine for one cycle (5 min/22°C, 30 min/42°C, 5 
min/85°C, Hold at 4°C).  
The total volume (20ul) of cDNA was diluted in 80ul of RNase free H2O. 
Quantitative qRT-PCR 
Table 2.1: List of primers for qRT-PCR knockdown verification.  
DNA Sequence,  
Forward and Reverse Primer Name 
Associated 
Gene Position  Reference 
TCGAGCGCTGTCTATCGCA Crz-mRNA F Crz 291-309 NM_079626.3 
 TGGGATGGGCGCTGTTTT Crz-mRNA R Crz 404-387 
ACAAAAAGCGGTTGTCCTGG kin17-mRNA F kin17 975-994 NM_140955.4 
 ACCGTCTCCAAATGAGCTTGA kin17-mRNA R kin17 1079-1059 
GTGATAGCGCTGCCCTTTTG elk-mRNA F elk 646-665 NM_001299624.1 
 TCCAGATTGTTGCCCTCACC elk-mRNA R elk 784-765 
GTGGTGGCTCAAATGGGAGG Myo61F-mRNA F Myo61F 883-902 NM_167872.2 
 GCCATTGAGCCCATCTGTCA Myo61F-mRNA R Myo61F 1023-1004 
AAGAAGCGCACCAAGCACTTCATC RPL32-mRNA F RPL32   
TCTGTTGTCGATACCCTTGGGCTT RPL32-mRNA R RPL32   
 
Primer mix (10pmol/ul working concentration) was created as follows for each set of 
primers used: 
10ul of 0.1 nmol/ul P-forward, 10ul of 0.1 nmol/ul P-reverse, 80ul of nanopore H2O. 
The reaction mixture for each sample contained 20ul final volume 
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Reaction master mix (1 sample): 
1ul diluted primer set; 10ul 2X SYBR green mix; 7ul dH2O.  
We added 2ul of cDNA sample to each designated well, checking all wells to ensure 
samples are in the appropriate well. We used a riboprotein (RPL32) primer as the house 
keeping gene for each reaction. Plates were sealed and centrifuged in plate centrifuge for 20 
seconds.  
The reaction protocol was run in QuantStudio 3 (ThermoFisher, #A28136), with 
settings set to comparative CT (ΔΔCT) and SYBR green as our fluorescent dye. In addition, 
reaction volume was 20ul, and the cover temperature was set to 105.0°C.  
The qRT-PCR was run at 50.0°C for 2 minutes, 95.0°C for 10 minutes, followed by 
40 cycles of 95.0°C/15 sec; 60.0°C/60sec until the final dissociation step.  
For each ΔCT value, all ΔCT values were selected and individually divided by 20. 
We then calculated the ΔΔCT by using the formula 2^-ΔCT. The reference for each sample is 
the ΔΔCT value from the RpL32 equivalent well.  
 
Statistical Analysis 
Phenotypic data used in the GWAS was obtained by averaging the biological 
replicate measures for each genotype, so that each line was associated with two unique 
phenotypic data points (one for each dataset). 
Statistical methods used were performed in Prism Software (GraphPad). 
When referring to a simple t-test, the following parameters were applied. Two groups 
of data were compared using a standard, unpaired Welsh’s t-test comparison. For this 
method, significant p-value was set at 0.05.  
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When referring to an ANOVA test, the following parameters were applied. Data 
groups were compared to the control group, and a Bonferroni correction was applied to 
correct for the large number of comparisons being performed (>10). The significant p-value 
was also set at 0.05. All graphs obtained show mean ± SEM.  
 
Results 
 
Lysosome Density Phenotypes are More Variable in Natural Populations Than in 
Laboratory Strains.  
 
Figure 2.2: Variation of lysosome density phenotypes in the DGRP. Basal lysosome density 
phenotype across the panel is shown in A, while the variation lysosome density due to 
response to stress (quantified as a foldchange) is shown in B.  
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When looking at the phenotypic distribution across the panel, we observed a normal 
distribution across all lines in both the resting and stress datasets (Fig.2.2-A & B).  
 
Figure 2.3: Variation of lysosome density phenotypes under basal conditions. Line 177 A had 
the lowest basal activation, resulting in nothing but background stain. Comparatively, line 21 
B contained a high density of lysosomes, as evidenced by the distinct punctae  
Notably, Lines 177 and 21 (Fig.2.3) exhibited the most extreme phenotypes (lowest 
and highest baseline, respectively) for basal lysosome density.   
Lines 129 and 223 (Fig.2.4) exhibited extreme changes in lysosome density 
phenotypes after starvation (lowest and highest foldchange, respectively).  
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Figure 2.4: Variation of lysosome density phenotypes after starvation stress. Line 129 A&B 
exhibits a complete removal of lysosomes from the tissue following starvation. Line 223 
C&D exhibits a strong increase in lysosome density following starvation.   
When testing the two datasets for correlation between the two observed phenotypes, 
we found no significant correlation (Pearson correlation: r = 0.127). We cannot predict the 
behavior of a line based on either one of its phenotypes. 
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Figure 2.5: Schematic and visual representation of phenotypic variation throughout the 
DGRP. Five general categories were identified within the panel, with representative lines 
pictures above: a Line 138, b Line 142, c Line 555, d line 48, e Line 850 
During dissection, lines across the panel exhibited various phenotypes, ranging from 
a normal activation of the autophagy pathway to a complete disruption of the pathway 
characterized by a diminished lysosome activity post starvation challenge. 
Literature supports that lysosome presence in the cell increases after being challenged 
with starvation, however we did not expect to see the variety of other phenotypes recorded.  
 30 
Line 138 (Fig.2.5a), amongst others, exhibited activations patterns consistent with the 
lab strain, with Fed values centered around 1500 observable units and a foldchange activation 
value centered around 1.  
Line 142 (Fig.2.5b), amongst other, exhibited a "low baseline, normal activation" 
phenotype, with baseline values centered around 120 units and a foldchange centered on 2.  
Line 555 (Fig.2.5c), amongst others, exhibited a “low baseline, low activation” 
phenotype, with baseline values centered around 900 units and a foldchange centered on 0.6. 
Line 48 (Fig.2.5d), amongst others, exhibited a "High baseline, normal activation" 
phenotype, with baseline values centered around 4000 units and a foldchange centered on 1. 
Line 850 (Fig.2.5e), amongst others, exhibited a "High baseline, negative activation" 
phenotype, with baseline values centered around 3800 units and a foldchange centered on 
0.4.  
 
GWAS of Lysosome Density Phenotypes Within the DGRP Reveals Non-overlapping 
Datasets. 
Applying the MacKay lab GWAS protocol yielded, for each dataset, which SNPs 
were significantly correlated with the phenotype of interest. We recovered 105 SNPs 
associated with baseline phenotype, of which 66 were unique (Fig.2.6a). We recovered 399 
SNPs associated with stress response, of which 287 were unique (Fig.2.6b) The full 
accounting of each SNP call list can be found in Appendix A and B respectively for each 
dataset.  
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Figure 2.6: Manhattan plot of Single SNP GWAS for lysosome density phenotypes. a 
Correlation of SNP with variance of basal lysosome density. b Correlation of SNP with 
variance of stress induced lysosome density.  
After accounting for redundant SNPs associated with the same gene, and eliminating 
all intergenic SNPs, these SNPs correspond to 39, and 178 unique genes respectively, a 
combined pool of 217 potential regulators associated with lysosome density within the cell, 
and thus autophagy. When comparing the two datasets, we found an overlap of only 4 genes, 
showing that the gene sets most correlating with basal or stress induced lysosome density do 
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not overlap (Fig.2.7).  From this pool, likely candidates were further selected for 
confirmation experiments. 
 
Figure 2.7: Gene sets correlated with basal and stress induced lysosome density do not 
overlap. 
 
Functional Validation via RNAi Identified 4 Candidates as Regulators of Lysosome 
Density.  
After selection based on the criteria outlined in the methods, 41 candidates were 
selected for further analysis. The first round of RNAi testing on candidate genes yielded 
varied results. Lines were assessed against the genetic background of each line (Attp2 or 
Attp40) and statistical difference was evaluated using both an ANOVA test, and a simple t-
test.  
In the Attp2 background (Fig.2.8a), 6 genes were deemed significantly different from 
the control via one-way ANOVA testing, with a Bonferroni correction, all with a p-value less 
than 0.0001. Using a t-test analysis, 7 more genes were deemed significantly different from 
the control.  
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Figure 2.8: Lysosome density in S106-GS>UAS-RNAi males following RNAi induction. 
Each RNAi was controlled using its corresponding site specific UAS background, a in Attp2 
and b in Attp40.  
In the Attp40 background (Fig.2.8b), 6 genes were deemed significantly different 
from the control via one-way ANOVA testing, with a Bonferroni correction. The highest p-
value was 0.0432 (Glu-Rib), and the lowest was 0.0002 (kin17).  
Using a t-test analysis, 4 more genes were deemed significantly different from the 
control.  
Overall, results of this first round of RNAi were encouraging, and so a secondary set 
of candidates was culled from the first for further testing and confirmation. The secondary set 
comprised of the genes considered to be significantly different from the control by both the t-
test, and the ANOVA test. This resulted in 6 genes being selected in each background, for a 
total of 12 candidates being considered in the secondary analysis (Fig2.9).   
Of the 12 candidates, 4 showed a significant different between control and treatment, 
and are thus considered potential novel regulators of lysosome density and thus autophagy. 
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Figure 2.9: Lysosome density before and after induction of RNAi in S106-GS>UAS-RNAi 
males.  
 
Figure 2.10: kin17, elk, Myo61F and crz regulate lysosome density. 
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qRT-PCR Verification of Gene Knockdown Confirms Efficacy of UAS-RNAi Lines.   
 
Figure 2.11: qRT-PCR confirms gene knockdown in kin17, corazonin and elk. While the 
relative gene expression of elk was not significantly reduced, technical replicates support an 
overall reduction in protein mRNA. Myosin61F gene expression was not detectable.  
Quantitative RT-PCR was performed to confirm the knockdown efficiency of RNAi 
lines. In the case of both kin17 and corazonin (Fig.2.11a&b), a significant decrease in protein 
mRNA expression (p-value 0.0022 and 0.0245 respectively) was detected, thus confirming 
that the RNAi line can effectively down-regulate the expression of these genes. In addition, 
while elk did not show a statistically significant decrease (Fig.2.11.c), multiple technical 
replicates indicate that the down-regulation is present, despite the extremely low overall 
expression level. Finally, Myosin-61F expression was not detectable using this protocol.  
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Discussion 
The beauty of the panel created by the MacKay lab is that it relies not on man-mediated 
mutagenesis, but instead on freely occurring genetic variation. All strains in the DGRP panel 
were caught in the wild and inbred over twenty generations until isogenic [7]. This provides us 
with a unique window into natural genetic variation and showcases that complex behavior will 
vary greatly from individual to individual. Considering the low number of lines established and 
the close spatiotemporal location at capture, one might have expected the panel to lack diversity, 
when in fact the exact opposite was revealed. Not all flies collected were able to establish 
themselves through the inbreeding protocol; as such we cannot consider the DGRP to be a full 
sample of natural diversity. It is instead, a small snapshot, revealing only a fraction of the genetic 
diversity that can be found in the wild. This snapshot panel was then established as a database for 
Genome Wide Association Studies by the MacKay lab, generating a resource that other scientists 
may then use to ask further questions.    
Multiple studies have already utilized GWAS to generate novel interactors in complex 
traits such as aggression, stress response, and longevity, studies that were made possible by the 
intensive sequencing of all lines included in the DGRP [9–11]. 
It was then natural to leverage this tool to attempt a similar process in the field of 
autophagy. The base mechanistic pathway of autophagy is well categorized, with a 
comparatively simple system of protein complexes achieving a singular role, that of sequestering 
and degrading material within the cell. What is less understood, are the triggers that activate or 
inactivate this mechanism, through which we can gain both a better understanding of cellular 
mechanisms, but also potentially more tightly regulate the action of autophagy in clinical setting.  
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In this study, we focused on lysosome abundance within the cell; a system of indirect 
reporting that has previously been used to quantify autophagy activation within tissues. While 
this assay does not give a direct representation of the autophagy mechanism, it does allow the 
quantification of one of its main functional components, the lysosome. In addition, the dye we 
used (LysoTracker) is primarily effective on acidic vacuoles, which would include both the 
lysosome and the fused autolysosome [6]. This assay does not in itself give an account of the 
autophagic flux, which is the rate at which cargo is engulfed, degraded and released back into the 
cytoplasm. The concept and monitoring of autophagic flux is important to understand where and 
how a pathway may be disrupted, and without it, no solid conclusions can be made about the rate 
of autophagy within the cells. However, quantification of the lysosome and autolysosome does 
showcase an important autophagy-linked phenotype and is often one of the first steps in 
investigative experiments. 
During the phenotyping process, we observed multiple phenotypes both expected and 
unexpected, thus highlighting the phenotypic complexity available to us through this panel. 
While some lines behaved as literature would predict others seemed to still be viable despite 
obvious disruptions to the expected lysosome phenotype. GWAS is a wonderful method for 
generating large amounts of data, from which candidates must then be isolated. Since the method 
of GWAS itself relies on the correlation between individual SNPs and the phenotype being 
assayed, further testing is always necessary to identify which candidates are actually implicated.  
It is worth noting that the SNPs called up by the study did not contain any known 
autophagy gene. This is likely due to the underlying nature of the panel, and how it was 
established. The panel cannot contain extreme or lethal SNPs that would disrupt crucial cellular 
mechanisms, because individuals with those genotypes would be expunged from the panel 
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during the establishing processes. Established lines had to be isogenically stable, and able to 
persist through generations. This means that any major pathological SNP would not be present 
within the full panel genotype. As such, when querying the panel about genotype-phenotype 
correlations, all genes known to be crucial to the proper functionality of a pathway (here 
autophagy, represented indirectly by lysosome count within the cell) are likely to be functional 
and only rarely containing significantly disruptive SNPs. This allows the analysis itself to be 
more sensitive to unknown of autophagy that may act in concert with other lesser regulators. In 
effect, this type of study allows the study not of the major effectors of a pathway, but of the 
small potentially additive network of regulators that have not previously been identified by 
standard mutagenesis assays.   
In addition, the phenotype we are using as our base query is not itself solely the domain 
of autophagy. By using the lysosome as an indirect reporter of autophagy, we are actually 
assaying SNPs and genes most correlated with lysosome genesis rather than autophagy 
machinery. As a result, since known autophagy genes and regulators do not influence the bio 
mechanism of the lysosome, they are absent from the scree. This brings a strong caveat to our 
results, in that we can only make deductions based on gene involvement in lysosome 
mechanisms. It is known that lysosomes are an important part of autophagy function, and as such 
projection hypotheses can be generated from our data but will need to be further verified by 
assays directly measuring autophagy, not relying on indirect reporters.  
Overall the dataset skewed towards intergenic regions, which were not selected for the 
study due to the difficulties associated with studying these regions. We know that these regions 
are far from functionally inactive and that regulatory elements and even important cellular 
product may be generated in these regions. Both of these functions may have an impact on 
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cellular pathway activity, but the tools to study these regions are few and still being developed. 
We instead decided to focus on better-annotated regions of the genome, specifically SNPs 
associated with protein-coding regions. Due to the production of a quantifiable product, we could 
better study the effect of a gene by removing its product from the organisms through RNA 
interference.  
Our first trial consisted of 41 selected candidates, based on genic location, keywords and 
statistical correlation with the observed phenotype provided by the GWAS output. The first 
analysis yielded higher than expected numbers of significantly positive phenotypes. Each line 
was controlled against its genetic background (Attp2 and Attp40) following activation of the 
RNA interference.  
The first analysis allowed for top candidates to be selected for a secondary analysis using 
different control methods. The 6 genes most highly activated in each genetic background were 
selected for a secondary verification. Where before, only the active RNA interference was 
visualized, we now tested each line against itself as a control, active interference versus inactive. 
During the totality of the experiment, candidate gene names were obscured, and lines 
were only referred to by their Bloomington ID number. This was done to reduce bias, as genes 
were picked on a qualitative basis, with certain genes being picked as favored candidates. In this 
way, we hoped to reduce human error that would have prioritized, or inflated results associated 
with preferred candidates.  
The implication of Myosin-61F successfully disrupting the lysosome activity with the 
organism opens an interesting avenue of research. While this specific protein has not been 
associated with the lysosome (and autophagy) functional pathway, the myosin-kinesin family of 
protein is known to be involved in autophagosome transport and fusion to the lysosome [12, 13]. 
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This particular protein may be an as of yet unrecognized key player in this important step. It is 
also possible that Myosin-61F serves as a reporter of kind, signaling the cell that more lysosomes 
are needed when fusion events are successfully completed. This would explain why the removal 
of this protein caused the lysosome numbers in tissues to decrease. The sustaining signal was 
absent; therefore, the cell did not maintain large pools of lysosome.  
Elk was originally selected with other candidates for its involvement in ion transport, a 
behavior that is crucial for the proper function of the lysosome [14]. Without ion transport, this 
organelle is unable to maintain its acidic nature, and perform its function. As a result, we 
hypothesized that a disruption of proteins associated with this function would, in turn, disrupt the 
proper function of the lysosome, and by extension the autophagy mechanism. Our results showed 
that elk did not act as a positive regulator of lysosome count within the cell, instead acting as a 
negative regulator. When removed from the cell, lysosome count increased. As part of the K+ 
voltage gated ion family of proteins, elk may be responsible for the cation backflow necessary 
for the lysosome to maintain its acidity. This behavior however would not explain why after 
removal of this potentially crucial protein, lysosome number increased within the cell. It is 
possible that elk serves a secondary, negative regulatory function activating a negative feedback 
loop within the cell. As the protein is removed, the cell would compensate by inducing lysosome 
activity. This mechanism is as of yet not associated with elk or other members of its protein 
family but could be possible.  
In addition, we also identified kin17 as another potential negative regulator of autophagy. 
Little is known about this protein, apart from a putative DNA binding function due to a zinc-
finger motif. Many important regulators act at the DNA level, by regulating expressions of co-
factors. The binding site of kin17 is currently unknown but is hypothesized to correspond to 
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regulators of autophagy. In addition, the specific mechanisms of action are unknown, but further 
inquiries will be explored in future works. It is possible that further explorations would implicate 
kin17 as a transcription factor responsible for the regulation of transcription in either the ATG 
genes or lysosomal biogenesis pathways.  
Finally, the protein Corazonin was also isolated as a potential regulator. Corazonin is a 
neuropeptide and has so far only been described in cerebral and neuronal tissues, not fat bodies 
or other adipose-type tissues. However, this protein is also implicated in ethanol metabolism, and 
its function as a hormone does not preclude it from being excreted, and having a secondary 
function is tissues other than neuronal tissue. The connection to ethanol sensing and metabolism 
may link this protein as a sensory integrator, responsible for reacting to toxic stress and 
activating the autophagy system as an attempt to clear the toxic environment. In this sense, it 
would act as an indirect trigger of the pathway, rather than a direct one, and may not need to be 
expressed at the site of autophagy. 
There are also some limitations inherent to the DGRP panel, and this specific method of 
discovery. While recording phenotypes, some line exhibited extreme behaviors, which is the 
entire baseline for this analysis. However, once relevant SNPs and thus genes are isolated, the 
analysis is no longer conducted in the DGRP background and instead is moved to a single gene 
of interest model. This allows us to pinpoint genes as causative for our specific phenotype of 
interest but does not necessarily correlate back to the extreme phenotypes previously observed. 
Since the DGRP is not man-made, there was no way to control for the number of SNPs present 
in any one line, leading to a complex interaction of traits to create phenotypes. It is likely that 
extreme phenotypes observed in the panel are in fact the result of synergistic actions by multiple 
unique SNPs, as well as a mix of potential direct and indirect triggers.  
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Indeed, autophagy is a mechanism that can be triggered directly, by the currently known 
cascade of actions, but it can also be triggered indirectly by defects in other cellular processes 
causing a situation of stress. This forms one of the main difficulties in this type of study, 
entangling what is a direct or an indirect action. To that effect, isolated candidates need to be 
further vetted in a mechanistic manner, so as to support the predictive value of the panel. GWAS, 
in general, are shown to be strongly predictive tools but are in themselves not sufficient to 
establish causation. 
 
Conclusion 
 
GWAS is a successful and useful tool when analyzing complex phenotypes. This 
technique allowed the identification of 217 potential candidates involved in lysosome density 
regulation within the cell. Further RNAi validation confirmed that 4 candidates (kin17, elk, 
corazonin and Myo61F) have a functional link to lysosome density, either up or downregulating 
its activity within tissues. This screen solidifies the value of GWAS as a preliminary screen from 
which regulators can be further characterized.  
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CHAPTER 3.    GENERAL CONCLUSIONS 
Overall, this study shows the strength of this specific type of method in generating new 
candidates in the field of autophagy control and regulation. Generating these new candidates is 
crucial for research to move forward, as aging continues to be on the forefront of scientific minds 
everywhere. The direct mechanisms of autophagy have already been strongly tied to aging, but 
we currently lack a complete understanding of the other pathways and proteins linked to this 
process. It is in these secondary triggers that potential new therapeutic research can be 
undertaken. By better understanding how autophagy is triggered or repressed within the cell, 
which specific proteins play a role in integrating cellular signaling, we come closer to a complete 
picture of this complex trait. 
The amount of data generated by this screen far exceeds the scope of this experiment and 
warrants further examination. On the largest scale, this method has proven useful fruitful when 
considering novel actors and regulators when considering complex traits, both behavioral and 
mechanistic. Further phenotyping assays in this diverse panel will likely yield more data to 
analyze and further refine our understanding of cellular mechanisms. In relation to this specific 
study, we queried genes associated with a lysosomal activation phenotype due to starvation, but 
many other stress conditions could be assayed. In the context of aging, many other phenotypes 
could be recorded and queried including neuronal and cardiac health as lifespan increases or 
following an insult consistent with a disease model (cardiac insult in particular). This may yield 
better insight into how the organism responds to this type of acute or chronic stress and may lead 
to novel ways to both manage and treat those conditions in humans. 
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On a narrower scope, there is much data that was generated by this one screen that was 
not further investigated, which could in itself lead to more novel discoveries. The GWAS 
protocol yields SNPs it judges to be most correlated with the query phenotype, but that doesn't 
preclude a weakly correlated SNP from having an important effect. Further assaying gene-
associated SNPs could increase the pool of potential novel regulators.  
In addition, many of the highly correlated SNPs were not located in genic locations, with 
a direct impact on gene product, but rather in intergenic locations. It is known that those regions 
are not inactive, that some will code long-noncoding RNAs and that others are involved in 
activator/repressor protein interactions. This means that disruptions in those regions could have a 
major impact on protein concentration within the organism, and cascade down into disruption 
phenotypes. As such, studying the consequences of coding shifts within those regions may yield 
valuable data and deepen our understanding of specific cellular mechanisms. 
It should also be noted that while we validated the link between phenotype and protein 
knockdown (qPCR) for a select few candidates, this systematic screen is not sufficient to 
determine the exact mechanistic action of each selected candidate. Further experiments should be 
designed for each candidate to elucidate whether it is a direct or indirect trigger of the functional 
mechanism. 
Large phenotyping screens have a strong scientific presence because, by their very 
creation, they open the doors to the creation of large quantities of hypotheses. The amount of 
data generated by this screen is immense, and only a very small portion of it has at this point 
been investigated. The DGRP panel allows us to gather massive amounts of data, and 
subsequently comb through it in search of scientific novelty. In this way, this study is not unique. 
What does make it unique, is its value as a well of potential information to be mined, and the fact 
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that by existing, it allows research to be conducted multiple times on the same dataset. This study 
isolated 4 potential novel regulators of lysosome behavior within the cell, out of 217 other 
potential candidate genes. This may sound like a small number, but this marks only the 
beginning of discoveries. More studies can now be conducted, both on the data as a whole, and 
the particular candidates.  
In addition, research in autophagy, and by extension aging and longevity is crucial to 
better understand the processes we undergo as we age and prevent the damages that come with 
this process. As we research and understand more, we can prevent damage and repair it when it 
happens. The implications of this type of research are wide and far-reaching, as they can affect 
therapeutic strategies, pharmaceutical ones (like the major discoveries on rapamyacin did) and 
affect how we engage with our environment. Current strategies are focused on increasing 
lifespan but gaining a better understanding of machinery at its basest level will also help us 
increase our health span. If we understand what damages a cell or a tissue as it ages, and how 
that cell is mechanistically going to respond to particular types of stress, we can prevent and 
preempt those actions. This may seem like a far of future, but it starts with three potential new 
regulators isolated in a screen such as this 
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APPENDIX A.    R CODE 
#Load libraries 
library("lmerTest") 
library("rmarkdown") 
library("gdata") 
library("RColorBrewer") 
library("reshape") 
library("reshape2") 
library(qqman) 
library(data.table) 
#read gwas.all.assoc file 
gwas.result.fed <- read.table("gwas.all.assoc_152fed.txt", header = T, as.is = T) 
#split column "ID" into two columns based on "_", place them following the last column,  
#rename them "CHR" (chromosome) and "BP" (SNP location). 
gwas.result.fed$CHR = as.character(lapply(strsplit(as.character(gwas.result.fed$ID), 
split="_"), "[", 1)) 
gwas.result.fed$BP = as.character(lapply(strsplit(as.character(gwas.result.fed$ID), 
split="_"), "[", 2)) 
 
#Rename column:SingleMixedPval, ID. (Four columns are used to make manhattan  
#Make sure reshape or reshape2 was loaded last if dplyer is also loaded 
gwas.result.fed <- rename(gwas.result.fed, c( SingleMixedPval = "P", ID = "SNP")) 
#Rename chromosome: 
gwas.result.fed[gwas.result.fed=="X"] <- 11 
gwas.result.fed[gwas.result.fed=="2L"] <- 21 
gwas.result.fed[gwas.result.fed=="2R"] <- 22 
gwas.result.fed[gwas.result.fed=="3L"] <- 31 
gwas.result.fed[gwas.result.fed=="3R"] <- 32 
gwas.result.fed[gwas.result.fed=="4"] <- 44 
#Change column from factor to numeric: 
gwas.result.fed$CHR <- as.numeric(as.character(gwas.result.fed$CHR)) 
gwas.result.fed$BP <- as.numeric(as.character(gwas.result.fed$BP)) 
str(gwas.result.fed) 
head(gwas.result.fed) 
tail(gwas.result.fed) 
as.data.frame(table(gwas.result.fed$CHR)) 
manhattan(gwas.result.fed) 
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APPENDIX B.    FLY STOCKS 
RNAi Drivers 
ywR;S106-GS-gal4 
w;Da-GS-gal4 
DGRP Fly Stock 
Table B.1: DGRP Fly Stock 
FBID_KEY CLASSIFICATION COLLECTION GENOTYPE SPECIES STOCK # 
FBst0028122 whole genome sequence BDSC DGRP-21 Dmel 28122 
FBst0028123 whole genome sequence BDSC DGRP-26 Dmel 28123 
FBst0028124 whole genome sequence BDSC DGRP-28 Dmel 28124 
FBst0055014 - BDSC DGRP-31 Dmel 55014 
FBst0055015 - BDSC DGRP-32 Dmel 55015 
FBst0028125 whole genome sequence BDSC DGRP-38 Dmel 28125 
FBst0029651 inbred line <newline> whole genome sequence BDSC DGRP-40 Dmel 29651 
FBst0028126 whole genome sequence BDSC DGRP-41 Dmel 28126 
FBst0028127 whole genome sequence BDSC DGRP-42 Dmel 28127 
FBst0028128 whole genome sequence BDSC DGRP-45 Dmel 28128 
FBst0055016 - BDSC DGRP-48 Dmel 55016 
FBst0029652 inbred line <newline> whole genome sequence BDSC DGRP-57 Dmel 29652 
FBst0028129 whole genome sequence BDSC DGRP-59 Dmel 28129 
FBst0028130 whole genome sequence BDSC DGRP-69 Dmel 28130 
FBst0028131 whole genome sequence BDSC DGRP-73 Dmel 28131 
FBst0028132 whole genome sequence BDSC DGRP-75 Dmel 28132 
FBst0028134 whole genome sequence BDSC DGRP-83 Dmel 28134 
FBst0028274 whole genome sequence BDSC DGRP-85 Dmel 28274 
FBst0028135 whole genome sequence BDSC DGRP-88 Dmel 28135 
FBst0028136 whole genome sequence BDSC DGRP-91 Dmel 28136 
FBst0028137 whole genome sequence BDSC DGRP-93 Dmel 28137 
FBst0055017 - BDSC DGRP-100 Dmel 55017 
FBst0028138 whole genome sequence BDSC DGRP-101 Dmel 28138 
FBst0028139 whole genome sequence BDSC DGRP-105 Dmel 28139 
FBst0028140 whole genome sequence BDSC DGRP-109 Dmel 28140 
FBst0028141 whole genome sequence BDSC DGRP-129 Dmel 28141 
FBst0028142 whole genome sequence BDSC DGRP-136 Dmel 28142 
FBst0028143 whole genome sequence BDSC DGRP-138 Dmel 28143 
FBst0028144 whole genome sequence BDSC DGRP-142 Dmel 28144 
FBst0028145 whole genome sequence BDSC DGRP-149 Dmel 28145 
FBst0028146 whole genome sequence BDSC DGRP-153 Dmel 28146 
FBst0028147 whole genome sequence BDSC DGRP-158 Dmel 28147 
FBst0028148 whole genome sequence BDSC DGRP-161 Dmel 28148 
FBst0028149 whole genome sequence BDSC DGRP-176 Dmel 28149 
FBst0028150 whole genome sequence BDSC DGRP-177 Dmel 28150 
FBst0028151 whole genome sequence BDSC DGRP-181 Dmel 28151 
FBst0028152 whole genome sequence BDSC DGRP-189 Dmel 28152 
FBst0028153 whole genome sequence BDSC DGRP-195 Dmel 28153 
FBst0025174 inbred line <newline> whole genome sequence BDSC DGRP-208 Dmel 25174 
FBst0028154 whole genome sequence BDSC DGRP-217 Dmel 28154 
FBst0028156 whole genome sequence BDSC DGRP-227 Dmel 28156 
FBst0028157 whole genome sequence BDSC DGRP-228 Dmel 28157 
FBst0029653 inbred line <newline> whole genome sequence BDSC DGRP-229 Dmel 29653 
FBst0028275 whole genome sequence BDSC DGRP-235 Dmel 28275 
FBst0028160 whole genome sequence BDSC DGRP-237 Dmel 28160 
FBst0028161 whole genome sequence BDSC DGRP-239 Dmel 28161 
FBst0028162 whole genome sequence BDSC DGRP-256 Dmel 28162 
FBst0028164 whole genome sequence BDSC DGRP-280 Dmel 28164 
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Table B.1 (Continued) 
 
FBID_KEY CLASSIFICATION COLLECTION GENOTYPE GENUS STOCK # 
FBst0028165 whole genome sequence BDSC DGRP-287 Dmel 28165 
FBst0025175 inbred line <newline> whole genome sequence BDSC DGRP-301 Dmel 25175 
FBst0025176 inbred line <newline> whole genome sequence BDSC DGRP-303 Dmel 25176 
FBst0025177 inbred line <newline> whole genome sequence BDSC DGRP-304 Dmel 25177 
FBst0037525 whole genome sequence <newline> wild type BDSC DGRP-306 Dmel 37525 
FBst0025179 inbred line <newline> whole genome sequence BDSC DGRP-307 Dmel 25179 
FBst0028166 whole genome sequence BDSC DGRP-309 Dmel 28166 
FBst0028276 whole genome sequence BDSC DGRP-310 Dmel 28276 
FBst0025180 inbred line <newline> whole genome sequence BDSC DGRP-313 Dmel 25180 
FBst0025181 inbred line <newline> whole genome sequence BDSC DGRP-315 Dmel 25181 
FBst0028167 whole genome sequence BDSC DGRP-317 Dmel 28167 
FBst0028168 whole genome sequence BDSC DGRP-318 Dmel 28168 
FBst0055018 - BDSC DGRP-319 Dmel 55018 
FBst0029654 inbred line <newline> whole genome sequence BDSC DGRP-320 Dmel 29654 
FBst0029655 inbred line <newline> whole genome sequence BDSC DGRP-321 Dmel 29655 
FBst0025182 inbred line <newline> whole genome sequence BDSC DGRP-324 Dmel 25182 
FBst0028171 whole genome sequence BDSC DGRP-332 Dmel 28171 
FBst0025183 inbred line <newline> whole genome sequence BDSC DGRP-335 Dmel 25183 
FBst0028172 whole genome sequence BDSC DGRP-336 Dmel 28172 
FBst0028173 whole genome sequence BDSC DGRP-338 Dmel 28173 
FBst0028174 whole genome sequence BDSC DGRP-340 Dmel 28174 
FBst0055019 - BDSC DGRP-348 Dmel 55019 
FBst0028176 whole genome sequence BDSC DGRP-350 Dmel 28176 
FBst0028177 whole genome sequence BDSC DGRP-352 Dmel 28177 
FBst0055020 - BDSC DGRP-354 Dmel 55020 
FBst0055038 - BDSC DGRP-355 Dmel 55038 
FBst0028178 whole genome sequence BDSC DGRP-356 Dmel 28178 
FBst0025184 inbred line <newline> whole genome sequence BDSC DGRP-357 Dmel 25184 
FBst0025185 inbred line <newline> whole genome sequence BDSC DGRP-358 Dmel 25185 
FBst0028179 whole genome sequence BDSC DGRP-359 Dmel 28179 
FBst0025186 inbred line <newline> whole genome sequence BDSC DGRP-360 Dmel 25186 
FBst0028180 whole genome sequence BDSC DGRP-361 Dmel 28180 
FBst0025187 inbred line <newline> whole genome sequence BDSC DGRP-362 Dmel 25187 
FBst0025445 inbred line <newline> whole genome sequence BDSC DGRP-365 Dmel 25445 
FBst0028181 whole genome sequence BDSC DGRP-367 Dmel 28181 
FBst0028182 whole genome sequence BDSC DGRP-370 Dmel 28182 
FBst0028183 whole genome sequence BDSC DGRP-371 Dmel 28183 
FBst0028184 whole genome sequence BDSC DGRP-373 Dmel 28184 
FBst0028185 whole genome sequence BDSC DGRP-374 Dmel 28185 
FBst0025188 inbred line <newline> whole genome sequence BDSC DGRP-375 Dmel 25188 
FBst0028186 whole genome sequence BDSC DGRP-377 Dmel 28186 
FBst0025189 inbred line <newline> whole genome sequence BDSC DGRP-379 Dmel 25189 
FBst0025190 inbred line <newline> whole genome sequence BDSC DGRP-380 Dmel 25190 
FBst0028188 whole genome sequence BDSC DGRP-381 Dmel 28188 
FBst0028189 whole genome sequence BDSC DGRP-382 Dmel 28189 
FBst0028190 whole genome sequence BDSC DGRP-383 Dmel 28190 
FBst0028191 whole genome sequence BDSC DGRP-385 Dmel 28191 
FBst0028192 whole genome sequence BDSC DGRP-386 Dmel 28192 
FBst0055021 - BDSC DGRP-390 Dmel 55021 
FBst0025191 inbred line <newline> whole genome sequence BDSC DGRP-391 Dmel 25191 
FBst0028194 whole genome sequence BDSC DGRP-392 Dmel 28194 
FBst0055022 - BDSC DGRP-395 Dmel 55022 
FBst0055023 - BDSC DGRP-397 Dmel 55023 
FBst0025192 inbred line <newline> whole genome sequence BDSC DGRP-399 Dmel 25192 
FBst0029656 inbred line <newline> whole genome sequence BDSC DGRP-405 Dmel 29656 
FBst0029657 inbred line <newline> whole genome sequence BDSC DGRP-406 Dmel 29657 
FBst0028278 whole genome sequence BDSC DGRP-409 Dmel 28278 
FBst0028196 whole genome sequence BDSC DGRP-426 Dmel 28196 
FBst0025193 inbred line <newline> whole genome sequence BDSC DGRP-427 Dmel 25193 
FBst0025194 inbred line <newline> whole genome sequence BDSC DGRP-437 Dmel 25194 
FBst0029658 inbred line <newline> whole genome sequence BDSC DGRP-439 Dmel 29658 
FBst0028197 whole genome sequence BDSC DGRP-440 Dmel 28197 
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FBst0028198 whole genome sequence BDSC DGRP-441 Dmel 28198 
FBst0028199 whole genome sequence BDSC DGRP-443 Dmel 28199 
FBst0028200 whole genome sequence BDSC DGRP-461 Dmel 28200 
FBst0025195 inbred line <newline> whole genome sequence BDSC DGRP-486 Dmel 25195 
FBst0028202 whole genome sequence BDSC DGRP-491 Dmel 28202 
FBst0028203 whole genome sequence BDSC DGRP-492 Dmel 28203 
FBst0028204 whole genome sequence BDSC DGRP-502 Dmel 28204 
FBst0055024 - BDSC DGRP-505 Dmel 55024 
FBst0028205 whole genome sequence BDSC DGRP-508 Dmel 28205 
FBst0028206 whole genome sequence BDSC DGRP-509 Dmel 28206 
FBst0029659 inbred line <newline> whole genome sequence BDSC DGRP-513 Dmel 29659 
FBst0025197 inbred line <newline> whole genome sequence BDSC DGRP-517 Dmel 25197 
FBst0055025 - BDSC DGRP-528 Dmel 55025 
FBst0029660 inbred line <newline> whole genome sequence BDSC DGRP-530 Dmel 29660 
FBst0028207 whole genome sequence BDSC DGRP-531 Dmel 28207 
FBst0028208 whole genome sequence BDSC DGRP-535 Dmel 28208 
FBst0055026 - BDSC DGRP-551 Dmel 55026 
FBst0025198 inbred line <newline> whole genome sequence BDSC DGRP-555 Dmel 25198 
FBst0055027 - BDSC DGRP-559 Dmel 55027 
FBst0028211 whole genome sequence BDSC DGRP-563 Dmel 28211 
FBst0055028 - BDSC DGRP-566 Dmel 55028 
FBst0028212 whole genome sequence BDSC DGRP-584 Dmel 28212 
FBst0028213 whole genome sequence BDSC DGRP-589 Dmel 28213 
FBst0028215 whole genome sequence BDSC DGRP-595 Dmel 28215 
FBst0055029 - BDSC DGRP-596 Dmel 55029 
FBst0055030 - BDSC DGRP-627 Dmel 55030 
FBst0055031 - BDSC DGRP-630 Dmel 55031 
FBst0055032 - BDSC DGRP-634 Dmel 55032 
FBst0025199 inbred line <newline> whole genome sequence BDSC DGRP-639 Dmel 25199 
FBst0028217 whole genome sequence BDSC DGRP-646 Dmel 28217 
FBst0028218 whole genome sequence BDSC DGRP-703 Dmel 28218 
FBst0025744 inbred line <newline> whole genome sequence BDSC DGRP-705 Dmel 25744 
FBst0025200 inbred line <newline> whole genome sequence BDSC DGRP-707 Dmel 25200 
FBst0025201 inbred line <newline> whole genome sequence BDSC DGRP-712 Dmel 25201 
FBst0025745 inbred line <newline> whole genome sequence BDSC DGRP-714 Dmel 25745 
FBst0028219 whole genome sequence BDSC DGRP-716 Dmel 28219 
FBst0028220 whole genome sequence BDSC DGRP-721 Dmel 28220 
FBst0028221 whole genome sequence BDSC DGRP-727 Dmel 28221 
FBst0025202 inbred line <newline> whole genome sequence BDSC DGRP-730 Dmel 25202 
FBst0025203 inbred line <newline> whole genome sequence BDSC DGRP-732 Dmel 25203 
FBst0028222 whole genome sequence BDSC DGRP-737 Dmel 28222 
FBst0028223 whole genome sequence BDSC DGRP-738 Dmel 28223 
FBst0028224 whole genome sequence BDSC DGRP-748 Dmel 28224 
FBst0028226 whole genome sequence BDSC DGRP-757 Dmel 28226 
FBst0028227 whole genome sequence BDSC DGRP-761 Dmel 28227 
FBst0025204 inbred line <newline> whole genome sequence BDSC DGRP-765 Dmel 25204 
FBst0025205 inbred line <newline> whole genome sequence BDSC DGRP-774 Dmel 25205 
FBst0028229 whole genome sequence BDSC DGRP-776 Dmel 28229 
FBst0028230 whole genome sequence BDSC DGRP-783 Dmel 28230 
FBst0025206 inbred line <newline> whole genome sequence BDSC DGRP-786 Dmel 25206 
FBst0028231 whole genome sequence BDSC DGRP-787 Dmel 28231 
FBst0028232 whole genome sequence BDSC DGRP-790 Dmel 28232 
FBst0028233 whole genome sequence BDSC DGRP-796 Dmel 28233 
FBst0025207 inbred line <newline> whole genome sequence BDSC DGRP-799 Dmel 25207 
FBst0028234 whole genome sequence BDSC DGRP-801 Dmel 28234 
FBst0028235 whole genome sequence BDSC DGRP-802 Dmel 28235 
FBst0028236 whole genome sequence BDSC DGRP-804 Dmel 28236 
FBst0028237 whole genome sequence BDSC DGRP-805 Dmel 28237 
FBst0028238 whole genome sequence BDSC DGRP-808 Dmel 28238 
FBst0028239 whole genome sequence BDSC DGRP-810 Dmel 28239 
FBst0028240 whole genome sequence BDSC DGRP-812 Dmel 28240 
FBst0028241 whole genome sequence BDSC DGRP-818 Dmel 28241 
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FBst0028242 whole genome sequence BDSC DGRP-819 Dmel 28242 
FBst0025208 inbred line <newline> whole genome sequence BDSC DGRP-820 Dmel 25208 
FBst0028243 whole genome sequence BDSC DGRP-821 Dmel 28243 
FBst0028244 whole genome sequence BDSC DGRP-822 Dmel 28244 
FBst0028245 whole genome sequence BDSC DGRP-832 Dmel 28245 
FBst0028246 whole genome sequence BDSC DGRP-837 Dmel 28246 
FBst0028247 whole genome sequence BDSC DGRP-843 Dmel 28247 
FBst0028248 whole genome sequence BDSC DGRP-849 Dmel 28248 
FBst0028249 whole genome sequence BDSC DGRP-850 Dmel 28249 
FBst0025209 inbred line <newline> whole genome sequence BDSC DGRP-852 Dmel 25209 
FBst0028250 whole genome sequence BDSC DGRP-853 Dmel 28250 
FBst0028251 whole genome sequence BDSC DGRP-855 Dmel 28251 
FBst0028252 whole genome sequence BDSC DGRP-857 Dmel 28252 
FBst0025210 inbred line <newline> whole genome sequence BDSC DGRP-859 Dmel 25210 
FBst0028253 whole genome sequence BDSC DGRP-861 Dmel 28253 
FBst0028254 whole genome sequence BDSC DGRP-879 Dmel 28254 
FBst0028255 whole genome sequence BDSC DGRP-882 Dmel 28255 
FBst0028256 whole genome sequence BDSC DGRP-884 Dmel 28256 
FBst0028279 whole genome sequence BDSC DGRP-887 Dmel 28279 
FBst0028257 whole genome sequence BDSC DGRP-890 Dmel 28257 
FBst0028258 whole genome sequence BDSC DGRP-892 Dmel 28258 
FBst0028259 whole genome sequence BDSC DGRP-894 Dmel 28259 
FBst0028260 whole genome sequence BDSC DGRP-897 Dmel 28260 
FBst0028261 whole genome sequence BDSC DGRP-900 Dmel 28261 
FBst0028262 whole genome sequence BDSC DGRP-907 Dmel 28262 
FBst0028263 whole genome sequence BDSC DGRP-908 Dmel 28263 
FBst0028264 whole genome sequence BDSC DGRP-911 Dmel 28264 
FBst0028265 whole genome sequence BDSC DGRP-913 Dmel 28265 
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Table B.2: UAS-RNAi Fly Stock 
STOCK	 CG#	 FBGN	 GENE	SYMBOL	 GENOTYPE	 GENE		LOC	 VECTOR	 TRIP#	
HAIRPIN		
LOCATION	 BALANCER	
31766	 CG1044	 FBgn0016794	 dos	 y1	v1;	P{TRiP}attP2	 3L	 VALIUM1	 HM04078	 attP2	 		31336	 CG10645	 FBgn0016031	 lama	 y1	v1;	P{TRiP}attP2	 3L	 VALIUM1	 JF01294	 attP2	 		57711	 CG11030	 FBgn0031736	 CG11030	 y1	sc	v1;	P{TRiP}attP2	 2L	 VALIUM20	 HMC04900	 attP2	 		28796	 CG11111	 FBgn0003218	 rdgB	 y1	v1;	P{TRiP}attP2	 X	 VALIUM10	 JF03224	 attP2	 		57400	 CG11883	 FBgn0033538	 CG11883	 y1	sc	v1;	P{TRiP}attP40	 2R	 VALIUM20	 HMC04704	 attP40	 		60469	 CG12296	 FBgn0013469	 klu	 y1	v1;	P{TRiP}attP40/CyO	 		 VALIUM20	 HMJ22839	 attP40	 CyO	64588	 CG13431	 FBgn0034521	 Mgat1	 y1	sc	v1;	P{TRiP}attP40	 2R	 VALIUM20	 HMC05607	 attP40	 		28762	 CG1416	 FBgn0032961	 CG1416	 y1	v1;	P{TRiP}attP2	 2L	 VALIUM10	 JF03190	 attP2	 		30489	 CG15532	 FBgn0010113	 hdc	 y1	sc	v1;	P{TRiP}attP2	 3R	 VALIUM10	 HM05231	 attP2	 		35038	 CG17077	 FBgn0003118	 pnt	 y1	sc	v1;	P{TRiP}attP2	 3R	 VALIUM20	 HMS01452	 attP2	 		60881	 CG17490	 FBgn0040009	 CG17490	 y1	v1;	P{TRiP}attP40/CyO	 		 VALIUM20	 HMJ22618	 attP40	 CyO	56932	 CG1977	 FBgn0250789	 alpha-Spec	 y1	sc	v1;	P{TRiP}attP40	 3L	 VALIUM20	 HMC04371	 attP40	 		28693	 CG2368	 FBgn0263102	 psq	 y1	v1;	P{TRiP}attP2	 2R	 VALIUM10	 JF03109	 attP2	 		28785	 CG2679	 FBgn0004919	 gol	 y1	v1;	P{TRiP}attP2	 2R	 VALIUM10	 JF03213	 attP2	 		28623	 CG2682	 FBgn0033015	 d4	 y1	v1;	P{TRiP}attP2	 2R	 VALIUM10	 JF03038	 attP2	 		58341	 CG2790	 FBgn0027599	 CG2790	 y1	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMJ22472	 attP40	 CyO	58276	 CG30268	 FBgn0050268	 CG30268	 y1	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMJ22359	 attP40	 CyO	58271	 CG30427	 FBgn0043792	 CG30427	 y1	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMJ22354	 attP40	 CyO	40923	 CG3161	 FBgn0262736	 Vha16-1	 y1	sc	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMS02171	 attP40	 CyO	mix	25943	 CG32975	 FBgn0028875	 nAcRalpha-34E	 y1	v1;	P{TRiP}attP2	 2L	 VALIUM10	 JF01963	 attP2	 		25999	 CG3302	 FBgn0013767	 Crz	 y1	v1;	P{TRiP}attP2	 3R	 VALIUM10	 JF02023	 attP2	 		
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29558	 CG3533	 FBgn0004055	 uzip	 y1	v1;	P{TRiP}attP2	 2R	 VALIUM10	 JF03237	 attP2	 		28032	 CG3619	 FBgn0000463	 Dl	 y1	v1;	P{TRiP}attP2	 3R	 VALIUM10	 JF02867	 attP2	 		57320	 CG4123	 FBgn0026061	 Mipp1	 y1	sc	v1;	P{TRiP}attP40	 3L	 VALIUM20	 HMS04521	 attP40	 CyO	fl	38310	 CG42343	 FBgn0259245	 CG42343	 y1	sc	v1;	P{TRiP}attP40	 X	 VALIUM20	 HMS01774	 attP40	 CyO	fl	40889	 CG42829	 FBgn0262018	 CadN2	 y1	v1/y1	sc	v1;	P{TRiP}attP40/CyO	 2L	 VALIUM20	 HMS02137	 attP40	 CyO	40908	 CG43743	 FBgn0264000	 Glu-RIB	 y1	sc	v1;	P{TRiP}attP40	 3L	 VALIUM20	 HMS02156	 attP40	 CyO	fl	54012	 CG4750	 FBgn0259795	 loopin-1	 y1	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMJ21436	 attP40	 CyO	mix	25821	 CG5076	 FBgn0011589	 elk	 y1	v1;	P{TRiP}attP2	 2R	 VALIUM10	 JF01839	 attP2	 		36697	 CG5083	 FBgn0038390	 Rbf2	 y1	sc	v1;	P{TRiP}attP2	 3R	 VALIUM20	 HMS01586	 attP2	 		55692	 CG5649	 FBgn0024887	 kin17	 y1	sc	v1;	P{TRiP}attP40	 3L	 VALIUM20	 HMC03906	 attP40	 		53313	 CG5996	 FBgn0032593	 trpgamma	 y1	sc	v1;	P{TRiP}attP2	 2L	 VALIUM20	 HMC03542	 attP2	 		27485	 CG6445	 FBgn0036715	 Cad74A	 y1	v1;	P{TRiP}attP2	 3L	 VALIUM10	 JF02635	 attP2	 		57385	 CG6472	 FBgn0034166	 CG6472	 y1	sc	v1;	P{TRiP}attP40	 2R	 VALIUM20	 HMC04689	 attP40	 		61830	 CG6744	 FBgn0037901	 CG6744	 y1	v1;	P{TRiP}attP40/CyO	 		 VALIUM20	 HMJ23313	 attP40	 CyO	34027	 CG7851	 FBgn0032013	 Scgalpha	 y1	sc	v1;	P{TRiP}attP2	 2L	 VALIUM20	 HMS00997	 attP2	 		33884	 CG8048	 FBgn0262511	 Vha44	 y1	sc	v1;	P{TRiP}attP2	 2R	 VALIUM20	 HMS00821	 attP2	 		56924	 CG8093	 FBgn0033999	 CG8093	 y1	sc	v1;	P{TRiP}attP40/CyO	 2R	 VALIUM20	 HMC04363	 attP40	 CyO	44661	 CG9023	 FBgn0015872	 Drip	 y1	sc	v1;	P{TRiP}attP2	 2R	 VALIUM20	 HMC02945	 attP2	 		41689	 CG9155	 FBgn0010246	 Myo61F	 y1	v1;	P{TRiP}attP2	 3L	 VALIUM20	 HMS02253	 attP2	 TM3,Sb	fl	
 
 
  
